The World Health Summit brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and health care systems worldwide.
Among the confirmed speakers are:
(in alphabetical order)
Tedros Adhanom Ghebreyesus Tedros Adhanom Ghebreyesus, elected for a five-year term in May 2017, is the first WHO Director-General to have been elected from multiple candidates by the World Health Assembly, and is the first person from the WHO African Region to serve as WHO's chief technical and administrative officer. Prior to this election, he served as Ethiopia’s Minister of Foreign Affairs from 2012–2016. He served as Ethiopia’s Minister of Health from 2005–2012. In 2009, he was elected as Chair of the Global Fund to Fight AIDS, Tuberculosis, and Malaria Board.
Mazda Adli is a renowned expert for treatment of depression and stress-associated diseases. His focus lies on the topic “mental health for the urban population” and on the treatment and prevention of stress-associated mental diseases in our modern living environment. In 2009, he co-founded the World Health Summit with Detlev Ganten.
Klaus M. Beier is in charge of the undergraduate training of medical students in sexual medicine as well as postgraduate training for physicians and psychologists in this field. He is in charge of the outpatient clinic of the institute which offers assessment and treatment of the full range of sexual disorders and gender dysphorias. His current research focuses on the prevention of child sexual abuse.
Seth Berkley is Gavi’s CEO and d medical doctor specializing in infectious disease epidemiology. He founded the International AIDS Vaccine Initiative (IAVI) in 1996, where he served as President and CEO. Prior to that, he worked for the Health Sciences Division at The Rockefeller Foundation, held posts at the Center for Infectious Diseases, the US Centers for Disease Control; the Massachusetts Department of Public Health; and the Carter Center, where he was assigned as an epidemiologist to the Ministry of Health in Uganda.
An accomplished Corneal Surgeon and Ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at the University of Montreal and within the greater province of Quebec. She was the International President of the World Health Summit 2017.
Prior to joining IFPMA, Thomas B. Cueni was Secretary General of Interpharma, the association of pharmaceutical research companies in Switzerland. For many years, he has been involved in the work of the European Federation of Pharmaceutical Industries and Associations, EFPIA, where he most recently served as Vice-Chair of the European Markets Committee and association representative on the Board. Prior to his appointment with Interpharma, he had a career as a journalist.
Working for the NCD Alliance since its founding in 2009, Katie Dain holds experience in organizational and strategic development, global advocacy and policy-making, program design as well as capacity-building in low- and middle-income countries. Before joining the NCD Alliance, she worked at the International Diabetes Federation in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
Diane Gashumba is the Rwandan Minister of Health of the Republic of Rwanda since October 4, 2016. From March 29, 2016, she served as the Minister of Gender and Family Promotion. She is a pediatrician by profession bringing in much experience in global maternal, newborn and child health with focus to gender issues. She was Director of two district hospitals and President of the National Women Council, thus bringing in strong experience in empowering women.
From 1983 until 2003, Harald zur Hausen was appointed as Scientific Director of the Deutsches Krebsforschungszentrum (German Cancer Research Center) in Heidelberg. He demonstrated in 1983 that cervical cancer in humans is caused by certain types of papilloma viruses (wart viruses), the genes from which are incorporated into the host cells' DNA. This discovery made it possible to develop a vaccine against cervical cancer, which had been the second most common tumor disease in women. For his discovery, he was awarded the Nobel Prize in 2008.
Martin Hirsch holds his current position since November 2013. He used to be Head of the Emmaüs France, High Commissioner for Active Solidarity against Poverty, and the High Commissioner for Youth in the government of François Fillon. He holds a master's degree in Neurobiology and is an alumnus of the École Normale Supérieure and of the École Nationale d'Administration.
Adnan Hyder is Professor and Associate Chair in the Department of International Health. He is the Director of the Health Systems program, Director of the International Injury Research Unit, and Associate Director of Global Programs at the Johns Hopkins Berman Institute of Bioethics. He serves as Co-Director of the NIH-Fogarty International Research Ethics Training Program at the Bloomberg School of Public Health.
Zsuzsanna Jakab has engaged first hand with many partners and WHO member states, contributing to the formulation of a joint health agenda for the WHO European Region and working for the WHO Europe in a range of senior management roles. Between 2002 and 2005, she was State Secretary at the Hungarian Ministry of Health, Social and Family Affairs. Prior to that, she served as the founding Director of the European Union's European Centre for Disease Prevention and Control in Stockholm, Sweden.
As a leading contributor to academic and political debates on governance for health at a national and global level, Ilona Kickbusch conducts global health diplomacy seminars in many regions and advises the World Health Organization (WHO). In Switzerland, she serves on the executive board of the Careum Foundation and as an advisor for Health 2020.
Susanna Krüger is CEO and board member at Save the Children Germany e.V since March 2016. Before, she founded and led GoodRoots, an advisory firm working with social investors on their impact measurement and organizational change. Her work experience includes over 14 years in development cooperation as well as humanitarian aid and its evaluation (Middle East, Asia and Africa), public administration reform, facilitation of organizational change in the non-profit sector, strategic philanthropy and impact investing efforts with large European foundations.
Stefan Oschmann is Chairman of the Executive Board and CEO of Merck. Before taking office at the end of April 2016, he served as Vice Chairman and Deputy CEO, with responsibility for Group Strategy, among other things. He joined Merck in 2011 as a member of the Executive Board and was responsible for the Healthcare business sector until the end of 2014. Before joining Merck, he worked for the U.S. pharma company MSD, where he served in a range of senior executive positions.
Peter Piot was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, as well as the Associate Director of the WHO Global Programme on AIDS. He was a co-discoverer of the Ebola virus, and his research focuses upon HIV/AIDS, sexually transmitted infections, and women’s health.
Xavier Prats Monné previously served as Deputy Director General (2010–14) and then Director General (2014–15) at the European Commission Directorate-General for Education and Culture. From 2007-10, he served as the Director for Employment Policy, Europe 2020 Strategy and International Relations in the field of employment and was one of the five founding members of the EC Impact Assessment Board. He holds degrees in Development Economics and in European Affairs.
A former Chief Executive Officer of Standard Chartered PLC, one of the world’s leading international banks, Peter Sands has been a research fellow at Harvard University since 2015, dividing his time between the Mossavar-Rahmani Center for Business and Government at Harvard Kennedy School and the Harvard Global Health Institute. In 2016-2017, he chaired the International Working Group on Financing Pandemic Preparedness at the World Bank. In 2015-16, he was Chairman of the U.S. National Academy of Medicine’s Commission on a Global Health Risk Framework for the Future.
Toyin Saraki is a philanthropist with two decades of advocacy covering maternal, newborn and child health, gender-based discrimination and violence, improving education, socio-economic empowerment and community livelihoods in Africa. She contributed largely to the establishment of the Lifestream Charity in 1993 and is a global advocate of the UN’s Every Woman Every Child campaign. She is on the board of the Global Foundation for the Elimination of Domestic Violence and the board of the Africa Justice Foundation.
Prior to his current position, BT Slingsby was the global head for access strategies at Eisai Co., Ltd. where he developed new business models for R&D and overlooked market access in the developing world. He has helped launch numerous start-ups in Japan and the U.S., and currently advises at the Graduate School of Medicine at the University of Tokyo and Kyoto University.
As president of the Robert Koch Institute, Lothar Wieler heads the central institution responsible for disease control and prevention in Germany. He is also a Professor of Veterinary Medicine at the Institute of Microbiology and Epizootics at the Free University in Berlin, a diplomat for the European College of Veterinary Public Health and a member of the German National Academy of Sciences Leopoldina.
Naoko Yamamoto brings nearly 30 years of experience working on health in Japan and most recently served as Senior Assistant Minister for Global Heath in Japan’s Ministry of Health, Labor and Welfare. In this capacity, she was heavily involved in Japan’s Global Health leadership. Prior to this role, she served in numerous health-related positions within the government of Japan. She holds a medical degree, a PhD in epidemiology and a Masters in Public Health.